Part of the toxicity associated with 6-ethyl-CDCA could potentially be attributed to its inability to undergo efficient phase II sulfation,223 which plays an important role in the elimination of native hydrophobic BAs.8 Taken together, roles for FXR modulation in therapies for a variety of liver disorders are not clear and therefore mixed at the present time. Here, NR1H4 is linked to liver disorder.